No link between Covid-19 vaccination and cancer has been established in scientific literature, but social media posts claim new research proves Pfizer's vaccine causes the disease. This is false; the experiment in which only one mouse developed a tumor has numerous flaws and was published in an unreliable journal, cancer specialists told AFP.
MyJournals.org - Science - Immunogenicity and safety of COVID-19 BNT162b2 booster vaccine in end-stage kidney disease patients receiving haemodialysis in Yogyakarta, Indonesia: a cohort prospective study (BMC Nephrology)
21st Austria weekly - Valneva Vienna Stock Exchange 30/12/2022 [pic1]Valneva: an Austrian/French specialty vaccine company reported further heterologous booster data from exploratory small clinical study for its inactivated COVID-19 vaccine VLA2001. The show that a dose of VLA2001 was well tolerated in previously BNT162b2 Pfizer/BioNTech- or mRNA 1273 Moderna-vaccinated participants confirming the favorable safety profile seen across all studies – including homologous settings. However this study additional elicited only marginally increased neutralizing antibody response. Company positive results following primary vaccination with ChAdOx1-S AstraZeneca August
Pharmaceutical giant Pfizer plans to sell its mRNA vaccine for the Wuhan coronavirus (COVID-19) at a 10,000 percent markup in 2023. A report by Quartz elaborated on the vaccine maker's plan [.]